Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

2.140 -0.090 (-4.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,124,259
Open 2.250
Bid (Size) 2.130 (1)
Ask (Size) 2.170 (15)
Prev. Close 2.230
Today's Range 2.120 - 2.255
52wk Range 1.180 - 3.840
Shares Outstanding 508,722,486
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
 
Via Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace

Performance

YTD
-10.83%
-10.83%
1 Month
-21.90%
-21.90%
3 Month
+3.38%
+3.38%
6 Month
-13.36%
-13.36%
1 Year
+67.19%
+67.19%

More News

Read More
Looking Into Geron's Return On Capital Employed
Via Benzinga
The Latest Analyst Ratings for Geron
Via Benzinga
Geron (GERN) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Earnings Outlook For Geron
Via Benzinga
2 Top Healthcare Stocks to Buy Right Now
Via The Motley Fool
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
From Geron Corporation
Via Business Wire
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
From Geron Corporation
Via Business Wire
SMID Cap Life Science Update: Are You An Investor Or Trader?
Via Talk Markets
7 A-Rated Penny Stocks Worth Betting On
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Via InvestorPlace
7 A-Rated Stocks to Buy for February 2023
Via InvestorPlace
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
7 A-Rated Stocks to Buy for Less Than $25
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
From Geron Corporation
Via Business Wire
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
From Geron Corporation
Via Business Wire
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
From Geron Corporation
Via Business Wire
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Exclusive: 5 Stocks To Watch From Benzinga Moneymaker Index, One Large Cap And 4 Small Cap Names
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.